ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Chronic Kidney Disease (CKD) Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: September 2024
|
Report Code: QYRE-Auto-24Y11896
Home | Market Reports | Health| Health Conditions
Global Chronic Kidney Disease CKD Drugs Industry Research Report Growth Trends and Competitive Analysis 2022 2028
BUY CHAPTERS

Chronic Kidney Disease (CKD) Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-24Y11896
Report
September 2024
Pages:95
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Pfizer Inc
Amgen Inc
Roche
GlaxoSmithKline(GSK )
Allergan plc
AbbVie
Kissei Pharmaceutical Co Ltd

Chronic Kidney Disease (CKD) Drugs - Market Size

The global market for Chronic Kidney Disease (CKD) Drugs was estimated to be worth US$ 13990 million in 2023 and is forecast to a readjusted size of US$ 15730 million by 2030 with a CAGR of 1.7% during the forecast period 2024-2030

Chronic Kidney Disease (CKD) Drugs - Market

Chronic Kidney Disease (CKD) Drugs - Market

Chronic Kidney Disease (CKD) Drugs are drugs for Chronic kidney disease, which also called chronic kidney failure, describes the gradual loss of kidney function.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs. The hospitals segment, which is the current market leader, is expected to continue its dominance in this market over the next few years.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Chronic Kidney Disease (CKD) Drugs, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Chronic Kidney Disease (CKD) Drugs by region & country, by Type, and by Application.
The Chronic Kidney Disease (CKD) Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chronic Kidney Disease (CKD) Drugs.
Market Segmentation

Scope of Chronic Kidney Disease (CKD) Drugs - Market Report

Report Metric Details
Report Name Chronic Kidney Disease (CKD) Drugs - Market
Forecasted market size in 2030 US$ 15730 million
CAGR 1.7%
Forecasted years 2024 - 2030
Segment by Type:
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Pfizer, Inc., Amgen, Roche, GlaxoSmithKline (GSK), Allergan, AbbVie, Kissei Pharmaceutical Co., Ltd.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Chronic Kidney Disease (CKD) Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Chronic Kidney Disease (CKD) Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Chronic Kidney Disease (CKD) Drugs in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Chronic Kidney Disease (CKD) Drugs - Market size in 2030?

Ans: The Chronic Kidney Disease (CKD) Drugs - Market size in 2030 will be US$ 15730 million.

Who are the main players in the Chronic Kidney Disease (CKD) Drugs - Market report?

Ans: The main players in the Chronic Kidney Disease (CKD) Drugs - Market are Pfizer, Inc., Amgen, Roche, GlaxoSmithKline (GSK), Allergan, AbbVie, Kissei Pharmaceutical Co., Ltd.

What are the Application segmentation covered in the Chronic Kidney Disease (CKD) Drugs - Market report?

Ans: The Applications covered in the Chronic Kidney Disease (CKD) Drugs - Market report are Hospitals, Specialty Clinics

What are the Type segmentation covered in the Chronic Kidney Disease (CKD) Drugs - Market report?

Ans: The Types covered in the Chronic Kidney Disease (CKD) Drugs - Market report are ACE Inhibitors, Angiotensin-II Receptor Blockers, Calcium Channel Blockers, Beta Blockers: BREVIBLOC, Bystolic, Others

Recommended Reports

Kidney Disease Drugs

Cardiac Related Drugs

Renal Treatment Therapies

1 Market Overview
1.1 Chronic Kidney Disease (CKD) Drugs Product Introduction
1.2 Global Chronic Kidney Disease (CKD) Drugs Market Size Forecast
1.2.1 Global Chronic Kidney Disease (CKD) Drugs Sales Value (2019-2030)
1.2.2 Global Chronic Kidney Disease (CKD) Drugs Sales Volume (2019-2030)
1.2.3 Global Chronic Kidney Disease (CKD) Drugs Sales Price (2019-2030)
1.3 Chronic Kidney Disease (CKD) Drugs Market Trends & Drivers
1.3.1 Chronic Kidney Disease (CKD) Drugs Industry Trends
1.3.2 Chronic Kidney Disease (CKD) Drugs Market Drivers & Opportunity
1.3.3 Chronic Kidney Disease (CKD) Drugs Market Challenges
1.3.4 Chronic Kidney Disease (CKD) Drugs Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Chronic Kidney Disease (CKD) Drugs Players Revenue Ranking (2023)
2.2 Global Chronic Kidney Disease (CKD) Drugs Revenue by Company (2019-2024)
2.3 Global Chronic Kidney Disease (CKD) Drugs Players Sales Volume Ranking (2023)
2.4 Global Chronic Kidney Disease (CKD) Drugs Sales Volume by Company Players (2019-2024)
2.5 Global Chronic Kidney Disease (CKD) Drugs Average Price by Company (2019-2024)
2.6 Key Manufacturers Chronic Kidney Disease (CKD) Drugs Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Chronic Kidney Disease (CKD) Drugs Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Chronic Kidney Disease (CKD) Drugs
2.9 Chronic Kidney Disease (CKD) Drugs Market Competitive Analysis
2.9.1 Chronic Kidney Disease (CKD) Drugs Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Chronic Kidney Disease (CKD) Drugs Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Kidney Disease (CKD) Drugs as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 ACE Inhibitors
3.1.2 Angiotensin-II Receptor Blockers
3.1.3 Calcium Channel Blockers
3.1.4 Beta Blockers: BREVIBLOC, Bystolic
3.1.5 Others
3.2 Global Chronic Kidney Disease (CKD) Drugs Sales Value by Type
3.2.1 Global Chronic Kidney Disease (CKD) Drugs Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Chronic Kidney Disease (CKD) Drugs Sales Value, by Type (2019-2030)
3.2.3 Global Chronic Kidney Disease (CKD) Drugs Sales Value, by Type (%) (2019-2030)
3.3 Global Chronic Kidney Disease (CKD) Drugs Sales Volume by Type
3.3.1 Global Chronic Kidney Disease (CKD) Drugs Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Chronic Kidney Disease (CKD) Drugs Sales Volume, by Type (2019-2030)
3.3.3 Global Chronic Kidney Disease (CKD) Drugs Sales Volume, by Type (%) (2019-2030)
3.4 Global Chronic Kidney Disease (CKD) Drugs Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Specialty Clinics
4.2 Global Chronic Kidney Disease (CKD) Drugs Sales Value by Application
4.2.1 Global Chronic Kidney Disease (CKD) Drugs Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Chronic Kidney Disease (CKD) Drugs Sales Value, by Application (2019-2030)
4.2.3 Global Chronic Kidney Disease (CKD) Drugs Sales Value, by Application (%) (2019-2030)
4.3 Global Chronic Kidney Disease (CKD) Drugs Sales Volume by Application
4.3.1 Global Chronic Kidney Disease (CKD) Drugs Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Chronic Kidney Disease (CKD) Drugs Sales Volume, by Application (2019-2030)
4.3.3 Global Chronic Kidney Disease (CKD) Drugs Sales Volume, by Application (%) (2019-2030)
4.4 Global Chronic Kidney Disease (CKD) Drugs Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Chronic Kidney Disease (CKD) Drugs Sales Value by Region
5.1.1 Global Chronic Kidney Disease (CKD) Drugs Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Chronic Kidney Disease (CKD) Drugs Sales Value by Region (2019-2024)
5.1.3 Global Chronic Kidney Disease (CKD) Drugs Sales Value by Region (2025-2030)
5.1.4 Global Chronic Kidney Disease (CKD) Drugs Sales Value by Region (%), (2019-2030)
5.2 Global Chronic Kidney Disease (CKD) Drugs Sales Volume by Region
5.2.1 Global Chronic Kidney Disease (CKD) Drugs Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Chronic Kidney Disease (CKD) Drugs Sales Volume by Region (2019-2024)
5.2.3 Global Chronic Kidney Disease (CKD) Drugs Sales Volume by Region (2025-2030)
5.2.4 Global Chronic Kidney Disease (CKD) Drugs Sales Volume by Region (%), (2019-2030)
5.3 Global Chronic Kidney Disease (CKD) Drugs Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Chronic Kidney Disease (CKD) Drugs Sales Value, 2019-2030
5.4.2 North America Chronic Kidney Disease (CKD) Drugs Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Chronic Kidney Disease (CKD) Drugs Sales Value, 2019-2030
5.5.2 Europe Chronic Kidney Disease (CKD) Drugs Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Chronic Kidney Disease (CKD) Drugs Sales Value, 2019-2030
5.6.2 Asia Pacific Chronic Kidney Disease (CKD) Drugs Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Chronic Kidney Disease (CKD) Drugs Sales Value, 2019-2030
5.7.2 South America Chronic Kidney Disease (CKD) Drugs Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Chronic Kidney Disease (CKD) Drugs Sales Value, 2019-2030
5.8.2 Middle East & Africa Chronic Kidney Disease (CKD) Drugs Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Chronic Kidney Disease (CKD) Drugs Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Chronic Kidney Disease (CKD) Drugs Sales Value
6.2.1 Key Countries/Regions Chronic Kidney Disease (CKD) Drugs Sales Value, 2019-2030
6.2.2 Key Countries/Regions Chronic Kidney Disease (CKD) Drugs Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Chronic Kidney Disease (CKD) Drugs Sales Value, 2019-2030
6.3.2 United States Chronic Kidney Disease (CKD) Drugs Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Chronic Kidney Disease (CKD) Drugs Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Chronic Kidney Disease (CKD) Drugs Sales Value, 2019-2030
6.4.2 Europe Chronic Kidney Disease (CKD) Drugs Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Chronic Kidney Disease (CKD) Drugs Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Chronic Kidney Disease (CKD) Drugs Sales Value, 2019-2030
6.5.2 China Chronic Kidney Disease (CKD) Drugs Sales Value by Type (%), 2023 VS 2030
6.5.3 China Chronic Kidney Disease (CKD) Drugs Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Chronic Kidney Disease (CKD) Drugs Sales Value, 2019-2030
6.6.2 Japan Chronic Kidney Disease (CKD) Drugs Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Chronic Kidney Disease (CKD) Drugs Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Chronic Kidney Disease (CKD) Drugs Sales Value, 2019-2030
6.7.2 South Korea Chronic Kidney Disease (CKD) Drugs Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Chronic Kidney Disease (CKD) Drugs Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Chronic Kidney Disease (CKD) Drugs Sales Value, 2019-2030
6.8.2 Southeast Asia Chronic Kidney Disease (CKD) Drugs Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Chronic Kidney Disease (CKD) Drugs Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Chronic Kidney Disease (CKD) Drugs Sales Value, 2019-2030
6.9.2 India Chronic Kidney Disease (CKD) Drugs Sales Value by Type (%), 2023 VS 2030
6.9.3 India Chronic Kidney Disease (CKD) Drugs Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Pfizer, Inc.
7.1.1 Pfizer, Inc. Company Information
7.1.2 Pfizer, Inc. Introduction and Business Overview
7.1.3 Pfizer, Inc. Chronic Kidney Disease (CKD) Drugs Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Pfizer, Inc. Chronic Kidney Disease (CKD) Drugs Product Offerings
7.1.5 Pfizer, Inc. Recent Development
7.2 Amgen
7.2.1 Amgen Company Information
7.2.2 Amgen Introduction and Business Overview
7.2.3 Amgen Chronic Kidney Disease (CKD) Drugs Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Amgen Chronic Kidney Disease (CKD) Drugs Product Offerings
7.2.5 Amgen Recent Development
7.3 Roche
7.3.1 Roche Company Information
7.3.2 Roche Introduction and Business Overview
7.3.3 Roche Chronic Kidney Disease (CKD) Drugs Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Roche Chronic Kidney Disease (CKD) Drugs Product Offerings
7.3.5 Roche Recent Development
7.4 GlaxoSmithKline (GSK)
7.4.1 GlaxoSmithKline (GSK) Company Information
7.4.2 GlaxoSmithKline (GSK) Introduction and Business Overview
7.4.3 GlaxoSmithKline (GSK) Chronic Kidney Disease (CKD) Drugs Sales, Revenue and Gross Margin (2019-2024)
7.4.4 GlaxoSmithKline (GSK) Chronic Kidney Disease (CKD) Drugs Product Offerings
7.4.5 GlaxoSmithKline (GSK) Recent Development
7.5 Allergan
7.5.1 Allergan Company Information
7.5.2 Allergan Introduction and Business Overview
7.5.3 Allergan Chronic Kidney Disease (CKD) Drugs Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Allergan Chronic Kidney Disease (CKD) Drugs Product Offerings
7.5.5 Allergan Recent Development
7.6 AbbVie
7.6.1 AbbVie Company Information
7.6.2 AbbVie Introduction and Business Overview
7.6.3 AbbVie Chronic Kidney Disease (CKD) Drugs Sales, Revenue and Gross Margin (2019-2024)
7.6.4 AbbVie Chronic Kidney Disease (CKD) Drugs Product Offerings
7.6.5 AbbVie Recent Development
7.7 Kissei Pharmaceutical Co., Ltd.
7.7.1 Kissei Pharmaceutical Co., Ltd. Company Information
7.7.2 Kissei Pharmaceutical Co., Ltd. Introduction and Business Overview
7.7.3 Kissei Pharmaceutical Co., Ltd. Chronic Kidney Disease (CKD) Drugs Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Kissei Pharmaceutical Co., Ltd. Chronic Kidney Disease (CKD) Drugs Product Offerings
7.7.5 Kissei Pharmaceutical Co., Ltd. Recent Development
8 Industry Chain Analysis
8.1 Chronic Kidney Disease (CKD) Drugs Industrial Chain
8.2 Chronic Kidney Disease (CKD) Drugs Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Chronic Kidney Disease (CKD) Drugs Sales Model
8.5.2 Sales Channel
8.5.3 Chronic Kidney Disease (CKD) Drugs Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
FEATURED COMPANIES
Pfizer Inc
Amgen Inc
Roche
GlaxoSmithKline(GSK )
Allergan plc
AbbVie
Kissei Pharmaceutical Co Ltd
List of Tables
    Table 1. Chronic Kidney Disease (CKD) Drugs Market Trends
    Table 2. Chronic Kidney Disease (CKD) Drugs Market Drivers & Opportunity
    Table 3. Chronic Kidney Disease (CKD) Drugs Market Challenges
    Table 4. Chronic Kidney Disease (CKD) Drugs Market Restraints
    Table 5. Global Chronic Kidney Disease (CKD) Drugs Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Company (2019-2024)
    Table 7. Global Chronic Kidney Disease (CKD) Drugs Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Chronic Kidney Disease (CKD) Drugs Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Chronic Kidney Disease (CKD) Drugs Price by Company (2019-2024) & (USD/Unit)
    Table 10. Key Manufacturers Chronic Kidney Disease (CKD) Drugs Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Chronic Kidney Disease (CKD) Drugs Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Chronic Kidney Disease (CKD) Drugs
    Table 13. Global Chronic Kidney Disease (CKD) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Kidney Disease (CKD) Drugs as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Chronic Kidney Disease (CKD) Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Chronic Kidney Disease (CKD) Drugs Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Chronic Kidney Disease (CKD) Drugs Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Chronic Kidney Disease (CKD) Drugs Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Chronic Kidney Disease (CKD) Drugs Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Chronic Kidney Disease (CKD) Drugs Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Chronic Kidney Disease (CKD) Drugs Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Chronic Kidney Disease (CKD) Drugs Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Chronic Kidney Disease (CKD) Drugs Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Chronic Kidney Disease (CKD) Drugs Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Chronic Kidney Disease (CKD) Drugs Price by Type (2019-2024) & (USD/Unit)
    Table 27. Global Chronic Kidney Disease (CKD) Drugs Price by Type (2025-2030) & (USD/Unit)
    Table 28. Global Chronic Kidney Disease (CKD) Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Chronic Kidney Disease (CKD) Drugs Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Chronic Kidney Disease (CKD) Drugs Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Chronic Kidney Disease (CKD) Drugs Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Chronic Kidney Disease (CKD) Drugs Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Chronic Kidney Disease (CKD) Drugs Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Chronic Kidney Disease (CKD) Drugs Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Chronic Kidney Disease (CKD) Drugs Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Chronic Kidney Disease (CKD) Drugs Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Chronic Kidney Disease (CKD) Drugs Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Chronic Kidney Disease (CKD) Drugs Price by Application (2019-2024) & (USD/Unit)
    Table 39. Global Chronic Kidney Disease (CKD) Drugs Price by Application (2025-2030) & (USD/Unit)
    Table 40. Global Chronic Kidney Disease (CKD) Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Chronic Kidney Disease (CKD) Drugs Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Chronic Kidney Disease (CKD) Drugs Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Chronic Kidney Disease (CKD) Drugs Sales Value by Region (2019-2024) & (%)
    Table 44. Global Chronic Kidney Disease (CKD) Drugs Sales Value by Region (2025-2030) & (%)
    Table 45. Global Chronic Kidney Disease (CKD) Drugs Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Chronic Kidney Disease (CKD) Drugs Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Chronic Kidney Disease (CKD) Drugs Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Chronic Kidney Disease (CKD) Drugs Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Chronic Kidney Disease (CKD) Drugs Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Chronic Kidney Disease (CKD) Drugs Average Price by Region (2019-2024) & (USD/Unit)
    Table 51. Global Chronic Kidney Disease (CKD) Drugs Average Price by Region (2025-2030) & (USD/Unit)
    Table 52. Key Countries/Regions Chronic Kidney Disease (CKD) Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Chronic Kidney Disease (CKD) Drugs Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Chronic Kidney Disease (CKD) Drugs Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Chronic Kidney Disease (CKD) Drugs Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Chronic Kidney Disease (CKD) Drugs Sales Volume, (2025-2030) & (K Units)
    Table 57. Pfizer, Inc. Company Information
    Table 58. Pfizer, Inc. Introduction and Business Overview
    Table 59. Pfizer, Inc. Chronic Kidney Disease (CKD) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 60. Pfizer, Inc. Chronic Kidney Disease (CKD) Drugs Product Offerings
    Table 61. Pfizer, Inc. Recent Development
    Table 62. Amgen Company Information
    Table 63. Amgen Introduction and Business Overview
    Table 64. Amgen Chronic Kidney Disease (CKD) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 65. Amgen Chronic Kidney Disease (CKD) Drugs Product Offerings
    Table 66. Amgen Recent Development
    Table 67. Roche Company Information
    Table 68. Roche Introduction and Business Overview
    Table 69. Roche Chronic Kidney Disease (CKD) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 70. Roche Chronic Kidney Disease (CKD) Drugs Product Offerings
    Table 71. Roche Recent Development
    Table 72. GlaxoSmithKline (GSK) Company Information
    Table 73. GlaxoSmithKline (GSK) Introduction and Business Overview
    Table 74. GlaxoSmithKline (GSK) Chronic Kidney Disease (CKD) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 75. GlaxoSmithKline (GSK) Chronic Kidney Disease (CKD) Drugs Product Offerings
    Table 76. GlaxoSmithKline (GSK) Recent Development
    Table 77. Allergan Company Information
    Table 78. Allergan Introduction and Business Overview
    Table 79. Allergan Chronic Kidney Disease (CKD) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 80. Allergan Chronic Kidney Disease (CKD) Drugs Product Offerings
    Table 81. Allergan Recent Development
    Table 82. AbbVie Company Information
    Table 83. AbbVie Introduction and Business Overview
    Table 84. AbbVie Chronic Kidney Disease (CKD) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 85. AbbVie Chronic Kidney Disease (CKD) Drugs Product Offerings
    Table 86. AbbVie Recent Development
    Table 87. Kissei Pharmaceutical Co., Ltd. Company Information
    Table 88. Kissei Pharmaceutical Co., Ltd. Introduction and Business Overview
    Table 89. Kissei Pharmaceutical Co., Ltd. Chronic Kidney Disease (CKD) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 90. Kissei Pharmaceutical Co., Ltd. Chronic Kidney Disease (CKD) Drugs Product Offerings
    Table 91. Kissei Pharmaceutical Co., Ltd. Recent Development
    Table 92. Key Raw Materials Lists
    Table 93. Raw Materials Key Suppliers Lists
    Table 94. Chronic Kidney Disease (CKD) Drugs Downstream Customers
    Table 95. Chronic Kidney Disease (CKD) Drugs Distributors List
    Table 96. Research Programs/Design for This Report
    Table 97. Key Data Information from Secondary Sources
    Table 98. Key Data Information from Primary Sources
List of Figures
    Figure 1. Chronic Kidney Disease (CKD) Drugs Product Picture
    Figure 2. Global Chronic Kidney Disease (CKD) Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Chronic Kidney Disease (CKD) Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Chronic Kidney Disease (CKD) Drugs Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Chronic Kidney Disease (CKD) Drugs Sales Price (2019-2030) & (USD/Unit)
    Figure 6. Chronic Kidney Disease (CKD) Drugs Report Years Considered
    Figure 7. Global Chronic Kidney Disease (CKD) Drugs Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Chronic Kidney Disease (CKD) Drugs Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Chronic Kidney Disease (CKD) Drugs Revenue in 2023
    Figure 10. Chronic Kidney Disease (CKD) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. ACE Inhibitors Picture
    Figure 12. Angiotensin-II Receptor Blockers Picture
    Figure 13. Calcium Channel Blockers Picture
    Figure 14. Beta Blockers: BREVIBLOC, Bystolic Picture
    Figure 15. Others Picture
    Figure 16. Global Chronic Kidney Disease (CKD) Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 17. Global Chronic Kidney Disease (CKD) Drugs Sales Value Market Share by Type, 2023 & 2030
    Figure 18. Global Chronic Kidney Disease (CKD) Drugs Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 19. Global Chronic Kidney Disease (CKD) Drugs Sales Volume Market Share by Type, 2023 & 2030
    Figure 20. Global Chronic Kidney Disease (CKD) Drugs Price by Type (2019-2030) & (USD/Unit)
    Figure 21. Product Picture of Hospitals
    Figure 22. Product Picture of Specialty Clinics
    Figure 23. Global Chronic Kidney Disease (CKD) Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 24. Global Chronic Kidney Disease (CKD) Drugs Sales Value Market Share by Application, 2023 & 2030
    Figure 25. Global Chronic Kidney Disease (CKD) Drugs Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 26. Global Chronic Kidney Disease (CKD) Drugs Sales Volume Market Share by Application, 2023 & 2030
    Figure 27. Global Chronic Kidney Disease (CKD) Drugs Price by Application (2019-2030) & (USD/Unit)
    Figure 28. North America Chronic Kidney Disease (CKD) Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 29. North America Chronic Kidney Disease (CKD) Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 30. Europe Chronic Kidney Disease (CKD) Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 31. Europe Chronic Kidney Disease (CKD) Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 32. Asia Pacific Chronic Kidney Disease (CKD) Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 33. Asia Pacific Chronic Kidney Disease (CKD) Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 34. South America Chronic Kidney Disease (CKD) Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 35. South America Chronic Kidney Disease (CKD) Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 36. Middle East & Africa Chronic Kidney Disease (CKD) Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 37. Middle East & Africa Chronic Kidney Disease (CKD) Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 38. Key Countries/Regions Chronic Kidney Disease (CKD) Drugs Sales Value (%), (2019-2030)
    Figure 39. Key Countries/Regions Chronic Kidney Disease (CKD) Drugs Sales Volume (%), (2019-2030)
    Figure 40. United States Chronic Kidney Disease (CKD) Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 41. United States Chronic Kidney Disease (CKD) Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 42. United States Chronic Kidney Disease (CKD) Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 43. Europe Chronic Kidney Disease (CKD) Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 44. Europe Chronic Kidney Disease (CKD) Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 45. Europe Chronic Kidney Disease (CKD) Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 46. China Chronic Kidney Disease (CKD) Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 47. China Chronic Kidney Disease (CKD) Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 48. China Chronic Kidney Disease (CKD) Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 49. Japan Chronic Kidney Disease (CKD) Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 50. Japan Chronic Kidney Disease (CKD) Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 51. Japan Chronic Kidney Disease (CKD) Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 52. South Korea Chronic Kidney Disease (CKD) Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 53. South Korea Chronic Kidney Disease (CKD) Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 54. South Korea Chronic Kidney Disease (CKD) Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 55. Southeast Asia Chronic Kidney Disease (CKD) Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 56. Southeast Asia Chronic Kidney Disease (CKD) Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 57. Southeast Asia Chronic Kidney Disease (CKD) Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 58. India Chronic Kidney Disease (CKD) Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 59. India Chronic Kidney Disease (CKD) Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 60. India Chronic Kidney Disease (CKD) Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 61. Chronic Kidney Disease (CKD) Drugs Industrial Chain
    Figure 62. Chronic Kidney Disease (CKD) Drugs Manufacturing Cost Structure
    Figure 63. Channels of Distribution (Direct Sales, and Distribution)
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Global Renal Therapeutic Market Research Report 2025
Global Chronic Kidney Disease Medication Market Research Report 2024
Global Drugs to Treat Chronic Kidney Disease Market Research Report 2024
Late Stage Chronic Kidney Disease Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Renal Diseases Drug Market Insights Forecast to 2030
Global Chronic Kidney Disease CKD Treatment Market Research Report 2025
Global Chronic Kidney Disease Treatment Market Research Report 2025
Global Late Stage Chronic Kidney Disease Therapeutics Market Research Report 2024
End Stage Renal Disease Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Nephrology Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Renal Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global CKD and ESRD Treatment Market Research Report 2025
Global End Stage Kidney Disease Market Research Report 2024
Global End Stage Renal Disease Market Research Report 2024
Global Dialysis Drug Market Research Report 2024
Global Hemodialysis Drug Market Research Report 2024
Kidney Disease Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global End stage Renal Disease Therapeutics Market Research Report 2024
Global End Stage Renal Disease ESRD Treatment Market Research Report 2025
Global Chronic Kidney Disease Nutritional Supplement Market Research Report 2024

RELATED REPORTS

Global Drug-Free Pain Management Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33I16356
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Adult Artificial Heart Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32W16534
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Viral Vector Vaccine for Humans Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-23Z16367
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Cardioplegia Adapter Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33A16598
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions